zde se nacházíte:
Úvod > Projects
  • English
RX39 - shutdown July 2017

RX39 - shutdown July 2017

GlaxoSmithKline Pharmaceuticals SA, Rixensart, 04/2017 - 09/2017

GSK is one of the world's leading pharmaceutical and healthcare companies. GSK is global organisation with offices in over 100 countries and major research centers in the USA, Belgium and China. The mission of the company is to improve the quality of human life.

With a concern of continuous improvement, at GSK Belgium, numerous large, medium and small size projects are ongoing simultaneously on the sites in Rixensart and Wavre. This project encompassed mainly shutdown activities in one of Rixensart's buildings. The works included: 

  • replacement of a chiller
  • replacement of an AHU
  • replacement of black piping manifolds

Principal project data

Shutdown activities

Scope IPS

Project Preparation 

  • Procurement
  • Shutdown 
  • DTS planning
  • Execution preparation

Project Realization

  • Construction management
  • Commissioning
  • PED  

IPS operational unit(s)

  • IPS Belgium sa